Ignite Creation Date:
2025-12-25 @ 2:20 AM
Ignite Modification Date:
2026-02-06 @ 1:43 AM
Study NCT ID:
NCT05028634
Status:
COMPLETED
Last Update Posted:
2025-02-11
First Post:
2021-08-25
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety Study to Evaluate Immune Response of Vaccines in Participants With Relapsing Forms of Multiple Sclerosis Who Receive Ozanimod Compared to Non-Pegylated Interferon (IFN)-β or No Disease Modifying Therapy
Sponsor:
Celgene
Organization:
Conditions & Keywords Data
Conditions: